Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Particularly alcohol use disorder where the evidence is strongest
Its not recommended for those with a history of certain cancers, pancreatitis, or specific endocrine disorders
It may be a better fit for patients seeking more robust weight loss potential, patients with stronger appetite signals, or patients who did not get their desired response from semaglutide
If you take warfarin, direct oral anticoagulants, aspirin, or other blood thinners, check with your prescriber about the risk of bruising and whether any lab monitoring is needed
Serve with roasted carrots and parsnips
Shaw Key Takeaways Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, and 12 mg doses
US$ 29.93
US$ 28.81
US$ 21.34
